Open Water Investment
VC Fund
Seoul, South Korea
Open Water Investment is an investment firm.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 7%
Last updated:
For AI agents: llms.txt
Industries Open Water Investment invests in
SoftwareInformation TechnologyHealth CareManufacturingApps
Stages Open Water Investment invests in
Series ASeries BSeedSeries CVenture - Series Unknown
Countries Open Water Investment invests in
South KoreaIndiaMexico
Round sizes
Seed $1.7M–$2.6MSeries A $1.8M–$3.9MSeries B $4M–$21M
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1.7M–$2.6M
- Series A
- $1.8M–$3.9M
- Series B
- $4M–$21M
Investment Focus
Industry
- Software 5 (18%)
- Information Technology 5 (18%)
- Health Care 3 (11%)
- Manufacturing 3 (11%)
- Apps 2 (7%)
Stage
- Series A 9 (32%)
- Series B 7 (25%)
- Seed 4 (14%)
- Series C 3 (11%)
- Venture - Series Unknown 2 (7%)
Country
- South Korea 23 (82%)
- India 1 (4%)
- Mexico 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Lee Won-seok
Team leader
|
Team leader | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Solivis
|
Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time. | $13.7M / Series C / Jun 04, 2026 | |
Spark Biopharma
|
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring anddeveloping new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. ' | $21.4M / Venture - Series Unknown / May 11, 2026 | |
Quantum Aero
|
Quantum Aero is a Defense artificial intelligence company. | $2.6M / Seed / Mar 18, 2025 | |
SN Display
|
SN Display develops display materials using perovskite nanocrystal technology for color conversion layers used in next-generation screens. It focuses on improving color purity, efficiency, and visual performance for electronic display applications including smartphones, TVs, and emerging visual devices. The company works on material-level displaysolutions. for various uses cases in | Series A / Jun 01, 2024 | |
Dabeeo
|
Dabeeo, an AI technology company specializing in geospatial data, creates digital twin earth by digitizing earth's spatial through AI-powered data transformation. Leveraging its cutting-edge AI technologies, Dabeeo delivers the essential digital spatial analysis data and insights to customers across various industries, enhancing productivityand convenience. | $5.9M / Series B / Mar 28, 2024 | |
Sky Labs
|
Our company, Sky Labs, is developing a ring-type Cardio Tracker, CART to help continuous monitoring of atrial fibrillation which is difficult to diagnose even in a hospital in daily life.According to a disease statistics study released in 2004, atrial fibrillation is a very common chronic disease that occurs in 1 out of 4 people in their 40s orolder. As stated in the Atrial Fibrillation Report from the UK's Atrial Fibrillation Association in 2012, the biggest problem is that atrial fibrillation is not diagnosed in 1 in 2 patients because it is not accompanied by severe subjective symptoms and hard to find due to the intermittent properties.To diagnose atrial fibrillation, the following three features of continuous monitoring are essential. Our product, CART, is equipped with these features to fully maximize the benefits of continuous monitoring.1) Comfortability as a wearable device : You can always wear CART on a daily basis. Additionally, it is even water-proof and dust-proof. So, you don't have to take it off while taking a shower, or washing hands.2) No-user intervention : By just wearing it on any finger which fits for you, every measurement is performed on the background basis without any intervention.3) Medical proof & Accuracy : Diagnosis is based on the conventional diagnosis method of cardiologists.By simply wearing CART on user's finger, CART continuously detects atrial fibrillation without any user intervention. CART detects and records atrial fibrillation, so users can track and manage their heart health status. In addition, users can diagnose atrial fibrillation whenever they want and see the results on their smartphone. By merely tapping CART, users can make event logs and analyze atrial fibrillation data at that moment when it occurs. Finally, the collected atrial fibrillation data can be used to help the physician diagnose of the atrial fibrillation.Initial target market is 0.2 million atrial fibrillation patients in Finland. Total target market is 300 million people to diagnose atrial fibrillation and tens of million subjects in clinical trials.Sky Labs is currently conducting clinical trials with the Seoul National University Hospital to verify the device's performance and is analyzing clinical data on heart disease. And, Sky Labs is working with global pharmaceutical company Bayer to make innovative healthcare business. | $15.4M / Series C / Sep 22, 2023 | |
GTL Co., Ltd.
|
GTL manufactures hydraulic equipment, mechanical parts, industrial robots and automation equipment or aircraft and spacecraft parts. | $2.2M / Series A / Aug 09, 2023 | |
True Balance
|
True Balance is a digital wallet owned and operated by Balancehero India Private Limited (BHI), that enables users to access utility bill payment, loan recharge, insurance, and other financial products. With 70 million users, True Balance aims to serve India with utility payments financial platform for the unbanked users to serve their money forliving requirements. Affinit is a non-banking financial company (NBFC) licensed by the Reserve Bank of India (RBI), provides digital financial services through TrueBalance.It was launched in 2014 by Mr. Charlie Lee as CEO, an alumnus of the University of Chicago. | $22.3M / Debt Financing / Aug 09, 2023 | |
houyhnhnms
|
houyhnhnms is a company that directly develops all necessary contents regardless of physical life and digital life. In the Web 2 environment, we lead the digital transformation of brands, and in the Web 3 environment, we carry out various campaigns as a Full Stack Metaverse & NFTs Studio. Furthermore, we carry out Crypto Business to realize thetoken economy that will become the mainstream of the Web 3 environment. | $2.3M / Seed / Nov 30, 2022 | |
meddi
|
Unfortunately, in Mexico only 5% of the population has access to a private health insurance. Everyone else, can have access to IMSS or ISSSTE. However, it is well-known that we are unhappy and unsatisfied with these institutions.At present doesn’t exist a prevention culture, if you don’t have healthy habits or if your genes simply are not on yourfavor, probably you could develop a complicated illness or health condition and next pay for medical attention in the private sector. We are developing an integral system of digital health, that allows to:- Access to a healthcare provider’s network that offer economical services for a timely attention. - A lifetime of medical data integrated and the possibility of sharing the information with the patient’s healthcare providers. - Predictive analysis to generate personalized follow-ups. - To help create a prevention culture we offer free services as: o Medical advice in person and through telemedicine. o Initial check-up and blood tests.All those services are included in a Basic annual membership for $199.00 pesos.The health data digitalization has the potential to improve access to healthcare, reduce expenses, and to reach people who wouldn’t have access to services.Today we are playing a part in the creation of new health care models, Do you join us? | $250K / Pre-Seed / Nov 02, 2022 | |
| See all 28 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Climate Investors
40,325 investors
Manufacturing Investors
24,696 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
Software VC Funds
31,919 investors
FAQ
What does Open Water Investment invest in?
Open Water Investment invests primarily in Software, Information Technology and Health Care startups, most often at Series A and Series B stage. Most of the 28 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Open Water Investment's check size?
Open Water Investment typically joins rounds of $1.7M–$2.6M at Seed, $1.8M–$3.9M at Series A and $4M–$21M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Open Water Investment participates in.
How do I contact Open Water Investment?
Public channels for Open Water Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Open Water Investment?
The team at Open Water Investment includes Lee Won-seok (Team leader). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
